
Since 2001, MDFA has supported thousands of people each year with information about macular disease.
Read MoreSince 2001, MDFA has supported thousands of people each year with information about macular disease.
Read MoreInherited retinal diseases (IRDs) have a significant impact on the Australian population, with approximately 1
Read MoreMacular Disease Foundation Australia (MDFA) has recently provided the Department of Health and Ageing with
Read MoreA successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.
Read MoreA years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.
Read MoreThe 2022 Supporter Survey results are in.
Read MoreSpecsavers and Macular Disease Foundation Australia have begun a strategic scoping partnership.
Read MoreResearchers confirm the AREDS2 formulation is safe for use over a decade.
Read MoreFaricimab has taken one step closer towards clinics in Australia.
Read More